1. Frontline Therapy of CLL: Evolving Treatment Paradigm

   • Craig S. Boddy
   • Shuo Ma

   Chronic Lymphocytic Leukemias (N Jain, Section Editor) 26 February 2018 Pages: 69 - 77

2. Prognostic Factors in the Era of Targeted Therapies in CLL

   • Prajwal Boddu
   • Alessandra Ferrajoli

   Chronic Lymphocytic Leukemias (N Jain, Section Editor) 23 February 2018 Pages: 78 - 90

3. Novel Therapies for Older Adults With Acute Lymphoblastic Leukemia

   • Nicholas J. Short
   • Hagop Kantarjian
   • Farhad Ravandi

   Acute Lymphocytic Leukemias (K Ballen and M Keng, Section Editors) 08 February 2018 Pages: 91 - 99

4. Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia

   • Victor M. Orellana-Noia
   • Michael G. Douvas

   Acute Lymphocytic Leukemias (K Ballen and M Keng, Section Editors) 14 February 2018 Pages: 100 - 108

   

5. Managing the Mental Distress of the Hematopoietic Stem Cell Transplant (HSCT) Patient: a Focus on Delirium

   • Joseph Bubalo

   Stem Cell Transplantation (R Maziarz, Section Editor) 05 February 2018 Pages: 109 - 113

6. Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies

   • Kristen B. McCullough
   • Miriam A. Hobbs
   • Prashant Kapoor

   Multiple Myeloma (P Kapoor, Section Editor) 15 February 2018 Pages: 114 - 124

7. Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities

   • Gunjan L. Shah
   • Navneet Majhail
   • Sergio Giralt

   Health Economics (N Khera, Section Editor) 27 February 2018 Pages: 125 - 134

   

8. Update on the Treatment of Anaplastic Large Cell Lymphoma

   • Khoan Vu
   • Weiyun Ai

   T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor) 07 March 2018 Pages: 135 - 141